Myocarditis presentation following COVID-19 virus infection versus COVID-19 vaccination

Area of Science:

• Cardiology
• Infectious Diseases
• Vaccinology

Background:

• Cardiac injury following COVID-19 infection is a significant concern with poor prognosis.
• While rare cases of myocarditis post-COVID-19 vaccination have been reported, they are typically mild.
• Understanding the differences in presentation between infection-induced and vaccine-induced myocarditis is crucial.

Purpose of the Study:

• To compare the clinical presentation and outcomes of myocarditis in patients following COVID-19 infection versus COVID-19 vaccination.
• To elucidate the distinct characteristics of severe COVID-19-related cardiac injury compared to rare vaccine-induced myocarditis.

Main Methods:

• Case study comparison of two patients presenting with myocarditis.
• Analysis of clinical course, symptoms, and outcomes for each patient.
• Review of existing literature on COVID-19 infection and vaccine-related cardiac events.

Main Results:

• COVID-19 infection led to severe myocarditis with a poor clinical course.
• Post-vaccination myocarditis presented as a rare and mild condition.
• Significant differences observed in the severity and prognosis of myocarditis based on etiology (infection vs. vaccine).

Conclusions:

• COVID-19 infection poses a greater risk for severe cardiac injury and mortality compared to COVID-19 vaccination.
• Vaccine-induced myocarditis is generally mild and rare, contrasting sharply with the potential severity of infection-induced cardiac complications.
• Clinical vigilance is necessary to differentiate between these conditions and manage patients appropriately.